Eliquis MDL Case Update
20 of 21 Eliquis Suits Cut from MDL Case
August 1, 2017
A federal judge in New York has dismissed 20 of the 21 Multi-District Litigation (MDL) cases against Pfizer and Bristol-Myers Squibb over the alleged risks of its blood-thinning drug Eliquis.
Twenty-four other cases in the MDL were dismissed in June.
The central issue in the cases is whether the drugmakers adequately informed doctors and patients of the risks involved with Eliquis, a drug that plaintiffs allege can cause severe gastrointestinal bleeding.
The one remaining case against the drug manufacturers is that of Sheila Fortner, a Tennessee woman who experienced gastrointestinal bleeding upon taking Eliquis for the purpose of reducing her risk of a stroke.
The case against Eliquis has not yet been decided. If you believe that Eliquis is responsible for any gastric distress you may have experienced, you may still have a case. Contact TheLawFirm.com for a free consultation.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!